Evidence map›Paper›PMID 22798068›Full record

Trial reportThe Journal of biological chemistry2012

Brain-selective kinase 2 (BRSK2) phosphorylation on PCTAIRE1 negatively regulates glucose-stimulated insulin secretion in pancreatic β-cells.

Xin-Ya Chen, Xiu-Ting Gu, Hexige Saiyin, Bo Wan, Yu-Jing Zhang, Jing Li, Ying-Li Wang, Rui Gao, Yu-Fan Wang, Wei-Ping Dong and 5 more

Open access · hybridAbstract readClinical Trial
In one paragraph

Trial report in The Journal of biological chemistry, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed, 1 pooled it
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 1 synthesis or guideline pooled it, 47 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Cyclin-dependent kinases: Masters of the eukaryotic universe.Wiley interdisciplinary reviews. RNA · 2023
    Review
  8. Discovery of 3-Amino-1International journal of molecular sciences · 2022
    Article
  9. Article
  10. Article
  11. Article
  12. AMPKα-like proteins as LKB1 downstream targets in cell physiology and cancer.Journal of molecular medicine (Berlin, Germany) · 2021
    Review
  13. Article
  14. The Role of CDKs and CDKIs in Murine Development.International journal of molecular sciences · 2020
    Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 7 institutions in 2 countries.

Xin-Ya ChenState Key Laboratory of Genetic Engineering, School of Life Science, Institutes of Biomedical Sciences, Fudan University, Shanghai, 200433, China.
Xiu-Ting Gu
Hexige Saiyin
Bo Wan
Yu-Jing Zhang
Jing Li
Ying-Li Wang
Rui Gao
Yu-Fan Wang
Wei-Ping Dong
Sonia M Najjar
Chen-Yu Zhang
Han-Fei Ding
Jun O Liu
Long Yu
Fudan University · CNNanjing University · CNShanghai First People's Hospital · CNState Key Laboratory of Genetic EngineeringAugusta University Health · USJohns Hopkins Medicine · USUniversity of Toledo · US

Funding

Regional Pilot And Feasibility Study Grants ProgramP30DK020572 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI DAVID P OLSON · 2013 to 2026
$24.3M
SUBSTRATES AND INSULIN RECEPTOR ENDOCYTOSISR01DK054254 · NIDDK · UNIVERSITY OF TOLEDO HEALTH SCI CAMPUS · PI NAJJAR, SONIA M. · 2000 to 2021
$5.8M
CEACAM1: A link between metabolic and cardiovascular diseasesR01HL112248 · NHLBI · UNIVERSITY OF TOLEDO HEALTH SCI CAMPUS · PI NAJJAR, SONIA M. · 2012 to 2016
$1.9M
The oncogenic basis of Bmi-1 in neuroblastoma developmentR01CA124982 · NCI · UNIVERSITY OF TOLEDO HEALTH SCI CAMPUS · PI DING, HAN-FEI · 2007 to 2010
$1.1M
Insulin resistance in the pathogenesis of NASHR01DK083850 · NIDDK · UNIVERSITY OF TOLEDO HEALTH SCI CAMPUS · PI NAJJAR, SONIA M. · 2009 to 2010
$749k
NCI NIH HHS CA124982NCI NIH HHS R01 CA124982NHLBI NIH HHS R01 HL112248NIDDK NIH HHS P30 DK020572NIDDK NIH HHS R01 DK054254NIDDK NIH HHS R01DK054254NIDDK NIH HHS R01 DK083850NIDDK NIH HHS R01DK083850
6 · The paper itself

Abstract

Brain-selective kinase 2 (BRSK2) has been shown to play an essential role in neuronal polarization. In the present study, we show that BRSK2 is also abundantly expressed in pancreatic islets and MIN6 β-cell line. Yeast two-hybrid screening, GST fusion protein pull-down, and co-immunoprecipitation assays reveal that BRSK2 interacts with CDK-related protein kinase PCTAIRE1, a kinase involved in neurite outgrowth and neurotransmitter release. In MIN6 cells, BRSK2 co-localizes with PCTAIRE1 in the cytoplasm and phosphorylates one of its serine residues, Ser-12. Phosphorylation of PCTAIRE1 by BRSK2 reduces glucose-stimulated insulin secretion (GSIS) in MIN6 cells. Conversely, knockdown of BRSK2 by siRNA increases serum insulin levels in mice. Our results reveal a novel function of BRSK2 in the regulation of GSIS in β-cells via a PCTAIRE1-dependent mechanism and suggest that BRSK2 is an attractive target for developing novel diabetic drugs.

Indexed as

AnimalsCell LineCyclin-Dependent KinasesCytoplasmGene Knockdown TechniquesGlucoseHumansInsulinInsulin-Secreting CellsInsulin SecretionMaleMiceMice, Inbred BALB CPhosphorylationProtein Serine-Threonine KinasesBrsk2 protein, humanBrsk2 protein, mouseCyclin-Dependent KinasesGlucoseInsulinPCTAIRE-1 protein kinaseProtein Serine-Threonine Kinases

Identifiers

PMID22798068
PMCPMC3436288
OpenAlexW2059107488

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.